Preconditioning the myocardium using short episodes of sublethal ischa
emia will delay the onset of necrosis during a subsequent lethal ischa
emic insult. This powerful protective adaptation of the myocyte has al
so been observed in other cell types. The potential for clinical appli
cation to benefit patients with a variety of pathological conditions h
as led to an expansion in our knowledge concerning the pathophysiology
of ischemia-reperfusion injury and the regulatory mechanisms underlyi
ng cellular metabolism. We feel it is timely to assess the current pos
ition in this field and provide a critical appraisal to facilitate fut
ure research. (C) 1998 Elsevier Science B.V.